Litigation Details for In Re Namenda Direct Purchaser Antitrust Litigation (S.D.N.Y. 2015)
✉ Email this page to a colleague
In Re Namenda Direct Purchaser Antitrust Litigation (S.D.N.Y. 2015)
Docket | ⤷ Sign Up | Date Filed | 2015-09-22 |
Court | District Court, S.D. New York | Date Terminated | 2020-05-27 |
Cause | 15:15 Antitrust Litigation | Assigned To | Colleen McMahon |
Jury Demand | Both | Referred To | Robert W. Lehrburger |
Patents | 6,469,012; 8,039,009 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in In Re Namenda Direct Purchaser Antitrust Litigation
Details for In Re Namenda Direct Purchaser Antitrust Litigation (S.D.N.Y. 2015)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2019-03-05 | 677 | United States Patent No. 5,250,534 United States Patent No. 6,469,012 United States Patent No. 644,077 … “red flags.” >! U.S, Patent No. 5,250,534. *1.S, Patent No. 6,469,012. 29 Case 1:15-cv-07488-CM-RWL…the U.S. patent. See Exhibit C, The number of claims in a patent varies from patent to patent. See id.…to a patent holder by a U.S. patent is defined by the issued claims of the patent — the “patented invention… 03/06/19 Page 9 of 220 PATENTING PROCESS A U.S. patent provides the patent holder with the right to | External link to document | |
2019-05-03 | 710 | Memorandum of Law in Opposition to Motion | also allowed Forest time to obtain U.S. Patent No. 8,039,009 for Namenda XR, which did not suffer from…fatal flaws of the ’703 patent, and which expired a decade after the ‘703 patent. In a draft letter…from the patent settlements, the desire to preclude additional challenges to the ‘703 patent (i.e., the…Namenda IR to drop their legal challenges to the ’703 Patent and delay launch of generic versions…date three months after the expiration of the ’703 Patent; and (2) using this improperly obtained | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |